肺心病患者急性发作期血液流变学和D-二聚体测定的临床意义

Clinical significance of changes of hemorheology and plasma D-dimer in patients with pulmonary heart disease at acute attack stage

  • 摘要: 目的 观察肺心病急性发作期治疗前后血液流变学指标、血气分析和血浆D-二聚体的变化,探讨其对肺心病病情严重程度及疗效判断的价值。方法 46例肺心病急性发作期患者给予为期2周的内科综合治疗。治疗前后分别测定血液流变学指标、血气分析及血浆D-二聚体的水平。结果 肺心病患者急性发作期血液流变学指标、血气分析和血浆D-二聚体水平(1.94±0.62mg/L)明显异常。治疗2周后,血液流变学各项指标、血pH和PaCO2及D-二聚体水平(0.79±0.46mg/L)与治疗前比较明显改善(P<0.05或P<0.01),PaO2改变则不明显(P>0.05)。治疗后与正常对照组比较,除PaCO2和PaO2差异有统计学意义外(P<0.05),其余各项指标差异无统计学意义(P>0.05)。结论 血浆D-二聚体检测可作为判定肺心病患者病情严重程度及疗效观察的指标。

     

    Abstract: Objective To observe the changes of hemorheological index, blood gas analysis results and plasma D-dimer level in patients with chronic pulmonary heart disease at acute attack stage before and after treatment in order to evaluate their value as an index of the disease severity and curative effect. Methods Forty-six patients with chronic pulmonary heart disease at acute attack stage underwent general medical treatment for 2 weeks. Changes in hemorheological index and blood gas analysis results were detected and plasma D-dimer level was measured before and after treatment. Results Compared with 45 healthy controls, the hemorheological index, blood gas analysis results and plasma D-dimer(1.94±0.62mg/L)were significantly abnormal in patients with chronic pulmonary heart disease at acute attack stage. The hemorheological index, blood pH, PaCO2 and plasma D-dimer level(0.79±0.46mg/L)were much more improved in patients with pulmonary heart disease after treatment than before treatment (P<0.05 or P<0.01), but no significant change was observed in PaO2. Compared with the controls, no significant difference was found in hemorheological index, blood pH, and plasma D-dimer level except for PaCO2 and PaO2 in the patients with chronic pulmonary heart disease (P>0.05). Conclusion The hemorheological index and blood gas analysis results are significantly abnormal in patients with chronic pulmonary heart disease at acute attack stage. Plasma D-dimer level can be used as an index to evaluate hypercoagulable state and pulmonary artery thrombosis and to judge the disease severity and curative effect in patients with chronic pulmonary heart disease.

     

/

返回文章
返回